HOME >> MEDICINE >> NEWS
Medical experts unite to raise awareness of risk, threat of blood clots

Council for Leadership on Thrombosis Awareness and Management formed to advance prevention and treatment of overlooked public health problem

TARRYTOWN, NY, February 14, 2002 -- Calling deep-vein thrombosis (DVT), or blood clots, an underestimated public health problem, the Council for Leadership On Thrombosis (CLOT) Awareness and Management announced its formation today to raise awareness, advance prevention and treatment, and reduce the dangers of DVT, a potentially life-threatening condition that affects approximately 2 million Americans per year.

Comprised of medical experts representing various specialties and affiliated with leading U.S. institutions, the Council plans to target both health care professionals and the general public with such major initiatives as a national DVT FREE screening program of 7,500 patients at more than 200 hospitals, and the ClotAlert Resource Center, a multifaceted campaign to educate consumers, physicians and health professionals about the risk factors and symptoms of DVT.

Deep-vein thrombosis represents one of the most commonly occurring and serious medical conditions, yet it has never received the same attention as heart attack or stroke, said Samuel Z. Goldhaber, MD, director of Venous Thromboembolism Research Group and Cardiac Centers Anticoagulation Service at Brigham and Womens Hospital in Boston, Mass., associate professor of medicine, Harvard Medical School, and co-chair of the Council for Leadership On Thrombosis Awareness and Management. The public is not nearly as educated about the potential health risk of DVT, nor is the public aware of the symptoms associated with blood clots. Our mission as a Council is to raise awareness of DVT so the public can recognize the symptoms and urgently seek medical help.

This is the first time that DVT has been portrayed as a true public health problem, said Victor Tapson, MD, associate professor, Division of Pulmonary Medicine, Department of
'"/>

Contact: Kristen Supchak
kristens@mcspr.com
908-234-9900
MCS
14-Feb-2002


Page: 1 2 3

Related medicine news :

1. Medically supervised drug injection facilities safer for users
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
4. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
5. New data on Orqis Medicals Cancion CRS to be reported at ACC
6. Medical technologies may hinder rather than help newborn survival
7. Medical meeting to feature research findings and disease prevention and health promotion sessions
8. LA BioMed Medical/Research briefs January 2005
9. Medical negligence system is secretive, unaccountable and unregulated
10. Dartmouth Medical School receives $1.6 million in AIDS funding
11. LA BioMed Medical/Research Briefs December 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Medical experts unite raise awareness risk threat blood clots

(Date:5/24/2015)... Metamora, Michigan (PRWEB) May 24, 2015 ... for concerns about hair loss. Although it is unclear ... that there are environmental factors such as metabolism, nutritional ... contribute. Since they offer a comprehensive approach to evaluating ... and post-menopausal woman, they can help patients find a ...
(Date:5/24/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... tests, which will allow them to take pressure measurements ... about bladder function. The doctor usually orders it if ... or overactive bladder (OAB). , Women’s Excellence ... that have problems with unwanted urinary leakage or problems ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 EnviroLeather™ ... launches “InkGard™ Plus” – a classic, rugged leather ... polymer allowing difficult stains, including ink, to be ... different colors suitable for corporate, healthcare, hospitality and ... line with EnviroLeather’s goal of developing products that ...
(Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
(Date:5/24/2015)... 2015 Medicx Media Solutions ... executive Jay Krihak as its head of programmatic ... up its expertise and leadership position in the ... Health sectors. , Krihak is an experienced, award-winning ... Krihak led sales planning teams for mobile platform ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2
(Date:5/22/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... the results of the Company,s 72-patient, placebo-controlled Phase ... for the treatment of dry eye patients using ... model.  The exploratory study was completed in late ... by the Company in a press release, identify ...
(Date:5/22/2015)... 20, 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ... "Guide to Prepare Application Dossiers for Oversea Medical ... " report to their offering. ... segment market of the most growth potentiality, which ... manufacturers and producers to penetrate such market. It ...
(Date:5/22/2015)... 2015 Today, Rhodes Pharmaceuticals L.P. announced that ... indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) ... The announcement comes just one ... U.S. Food and Drug Administration (FDA). ... methylphenidate capsule with an onset of effect of ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
Cached News: